Skip to content
Peptigraph home

Peptides for Growth hormone

The peptides people most often research for growth hormone, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated
Peptides listed
5
With human trials
4
FDA approved (any use)
2
Showing 5 peptides · ordered by search interest for this goal
  1. HGHRecombinant growth hormoneHuman RCT evidence, 4 of 4Clinical endocrinology 1997, PMID 9404448Human4768Animal602Summarised1FDA approved (prescription only)Overview
  2. IGF-1 LR3IGF-1 analogAnimal evidence, 2 of 4Journal of developmental origins of health and disease 2023, PMID 37114757Human17Animal73Summarised2Not FDA approved · research chemicalOverview
  3. IpamorelinGHRP (ghrelin receptor agonist)Human RCT evidence, 4 of 4Pharmaceutical research 1999, PMID 10496658Human4Animal7Summarised2Not FDA approved · research chemicalOverview
  4. CJC-1295GHRH analogHuman RCT evidence, 4 of 4The Journal of clinical endocrinology and metabolism 2006, PMID 16352683Human7Animal2Summarised4Not FDA approved · research chemicalOverview
  5. TesamorelinGHRH analogHuman RCT evidence, 4 of 4The Journal of clinical endocrinology and metabolism 2012, PMID 23015655Human26Animal2Summarised4FDA approved (Egrifta)Overview
Read this first

What this list does not show

Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.

Search interest is not evidence

This list follows what people search for and discuss. It says nothing about how well any peptide works.

Animal results may not carry over

Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.

Approval covers specific uses

An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.

Combinations are a separate question

Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.

Growth hormone and what it does

MedlinePlus says the pituitary gland makes growth hormone, which stimulates the growth of bone and other tissues.[6]

The page adds that children with too little of it may be very short and that treatment with growth hormone can stimulate growth.[6]

Secretagogues raise GH; only injected GH has outcome trials

Injected growth hormone has 4,768 human-only papers and 692 randomised trials in this ledger, whereas CJC-1295 has 7 human-only papers, ipamorelin 4, tesamorelin 26, and IGF-1 LR3 17 human-only papers against 73 animal ones.

Calculated from source our PubMed count ledger ledger (PubMed title/abstract counts, 2026-10-02); hgh human only 4768, animal only 602, rct 692; igf-1-lr3 human only 17, animal only 73, rct 0; ipamorelin human only 4, animal only 7, rct 1; cjc-1295 human only 7, animal only 2, rct 1; tesamorelin human only 26, animal only 2, rct 13. Formula: Counts copied from each peptide ledger: humanOnly = human studies not also tagged animal, animalOnly = animal studies not tagged human, rct = human randomised trials. They count papers mentioning the topic, not positive results.

A single CJC-1295 injection produced dose-dependent rises in plasma GH and IGF-I that outlasted the dose by days.[4]

After repeated CJC-1295 doses, IGF-I stayed above baseline for several weeks.[4]

In a human dose study, ipamorelin produced a single episode of GH release with a rapid decline.[3]

In rats and swine, ipamorelin released GH selectively without a matching ACTH or cortisol rise.[7]

Tesamorelin raised IGF-I in a randomised trial, while IGF-I fell slightly on placebo.[8]

DSIP did not change GH or prolactin in a small trial.[9]

IGF-1 LR3 did the opposite of raising GH in pigs, where mean plasma GH was lower during infusion.[10]

What FDA labels say growth hormone is for

The Norditropin label says it replaces endogenous GH in adults with growth hormone deficiency.[11]

The Increlex label limits mecasermin to growth failure from severe primary IGF-1 deficiency or GH gene deletion with neutralising antibodies, and says it is not a substitute for GH.[12]

Common questions

What are the best peptides for growth hormone?

CJC-1295, ipamorelin and tesamorelin all raise GH or IGF-I in people; the files give no trial that ranks them against each other.[8]

Which peptides increase growth hormone?

CJC-1295 raised plasma GH and IGF-I in a randomised study, and ipamorelin triggered GH release in humans.[4]

What is the best peptide for growth hormone?

No head-to-head study exists in the files, so none can be named best.[3]

Is growth hormone FDA approved?

Yes for specific conditions, for example adult growth hormone deficiency on the Norditropin label.[11]

Sources

  1. 1Two years of replacement therapy in adults with growth hormone deficiency.Clinical endocrinology · 1997PMID 9404448Accessed 2 Oct 2026
  2. 2Attenuated glucose-stimulated insulin secretion during an acute IGF-1 LR3 infusion into fetal sheep does not persist in isolated islets.Journal of developmental origins of health and disease · 2023PMID 37114757Accessed 2 Oct 2026
  3. 3Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.Pharmaceutical research · 1999PMID 10496658Accessed 2 Oct 2026
  4. 4Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.The Journal of clinical endocrinology and metabolism · 2006PMID 16352683Accessed 2 Oct 2026
  5. 5Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.The Journal of clinical endocrinology and metabolism · 2012PMID 23015655Accessed 2 Oct 2026
  6. 6Official web pageOfficial web page · web page
  7. 7Ipamorelin, the first selective growth hormone secretagogue.European journal of endocrinology · 1998PMID 9849822Accessed 2 Oct 2026
  8. 8Metabolic effects of a growth hormone-releasing factor in patients with HIV.The New England journal of medicine · 2007PMID 18057338Accessed 2 Oct 2026
  9. 9Delta sleep-inducing peptide administration does not influence growth hormone and prolactin secretion in normal women.Psychoneuroendocrinology · 1993PMID 8475226Accessed 2 Oct 2026
  10. 10Long [R3] insulin-like growth factor-I reduces growth, plasma growth hormone, IGF binding protein-3 and endogenous IGF-I concentrations in pigs.The Journal of endocrinology · 1997PMID 9488001Accessed 2 Oct 2026
  11. 11NORDITROPIN prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
  12. 12INCRELEX prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.